Yang H, Xu D, Schmid RA, Peng R-W. Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma. Ther Adv Med Oncol. 2020;12:175883592097142.

Article  Google Scholar 

Sauter JL, Dacic S, Galateau-Salle F, Attanoos RL, Butnor KJ, Churg A, et al. The 2021 WHO Classification of Tumors of the Pleura: Advances Since the 2015 Classification. J Thorac Oncol. 2022;17:608–22.

Article  PubMed  Google Scholar 

Van Kooten JP, Belderbos RA, Von Der Thüsen JH, Aarts MJ, Verhoef C, Burgers JA, et al. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study. Thorax. 2022;77:1260–7.

Article  PubMed  Google Scholar 

Sinn K, Mosleh B, Hoda MA. Malignant pleural mesothelioma: recent developments. Curr Opin Oncol. 2021;33:80–6.

Article  PubMed  CAS  Google Scholar 

Miyake N, Ochi N, Yamane H, Fukazawa T, Ikeda T, Yokota E, et al. Targeting ROR1 in combination with pemetrexed in malignant mesothelioma cells. Lung Cancer. 2020;139:170–8.

Article  PubMed  Google Scholar 

Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016;25:472–86.

Article  PubMed  PubMed Central  Google Scholar 

Monaco SE, Shuai Y, Bansal M, Krasinskas AM, Dacic S. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol. 2011;135:619–27.

Article  PubMed  Google Scholar 

Yoshimura M, Kinoshita Y, Hamasaki M, Matsumoto S, Hida T, Oda Y, et al. Highly expressed EZH2 in combination with BAP1 and MTAP loss, as detected by immunohistochemistry, is useful for differentiating malignant pleural mesothelioma from reactive mesothelial hyperplasia. Lung Cancer. 2019;130:187–93.

Article  PubMed  Google Scholar 

Hwang HC, Pyott S, Rodriguez S, Cindric A, Carr A, Michelsen C, et al. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. Am J Surg Pathol. 2016;40:714–8.

Article  PubMed  Google Scholar 

Shinozaki‐Ushiku A, Ushiku T, Morita S, Anraku M, Nakajima J, Fukayama M. Diagnostic utility of BAP 1 and EZH 2 expression in malignant mesothelioma. Histopathology. 2017;70:722–33.

Article  PubMed  Google Scholar 

Hakim SA, Abou Gabal HH. Diagnostic utility of BAP1, EZH2 and Survivin in differentiating pleural epithelioid mesothelioma and reactive mesothelial Hyperplasia: immunohistochemical study. Pathol Oncol Res. 2021;27:600073.

Article  PubMed  PubMed Central  Google Scholar 

Tolwani A, Matusiak M, Bui N, Forgó E, Varma S, Baratto L, et al. Prognostic relevance of the hexosamine biosynthesis pathway activation in leiomyosarcoma. npj Genom Med. 2021;6:30.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Oki T, Yamazaki K, Kuromitsu J, Okada M, Tanaka I. cDNA cloning and mapping of a novel subtype of Glutamine:fructose-6-phosphate Amidotransferase (GFAT2) in human and mouse. Genomics. 1999;57:227–34.

Article  PubMed  CAS  Google Scholar 

Szymura SJ, Zaemes JP, Allison DF, Clift SH, D’Innocenzi JM, Gray LG, et al. NF-κB upregulates glutamine-fructose-6-phosphate transaminase 2 to promote migration in non-small cell lung cancer. Cell Commun Signal. 2019;17:24.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, et al. GFPT2 -Expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung Adenocarcinoma. Cancer Res. 2018;78:3445–57.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Liu L, Pan Y, Ren X, Zeng Z, Sun J, Zhou K, et al. GFPT2 promotes metastasis and forms a positive feedback loop with p65 in colorectal cancer. Am J Cancer Res. 2020;10:2510–22.

PubMed  PubMed Central  CAS  Google Scholar 

Wang Q, Karvelsson ST, Kotronoulas A, Gudjonsson T, Halldorsson S, Rolfsson O. Glutamine-Fructose-6-Phosphate Transaminase 2 (GFPT2) is upregulated in breast epithelial–mesenchymal transition and responds to oxidative stress. Mol Cell Proteom. 2022;21:100185.

Article  CAS  Google Scholar 

Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell. 2012;21:297–308.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hardivillé S, Hart GW. Nutrient regulation of signaling, transcription, and cell physiology by O-GlcNAcylation. Cell Metab. 2014;20:208–13.

Article  PubMed  PubMed Central  Google Scholar 

Chiaradonna F, Ricciardiello F, Palorini R. The nutrient-sensing hexosamine biosynthetic pathway as the hub of cancer metabolic rewiring. Cells. 2018;7:53.

Article  PubMed  PubMed Central  Google Scholar 

Hart GW, Slawson C, Ramirez-Correa G, Lagerlof O. Cross talk between O-GlcNacylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem. 2011;80:825–58.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dong DL, Hart GW. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J Biol Chem. 1994;269:19321–30.

Article  PubMed  CAS  Google Scholar 

Wang ZV, Deng Y, Gao N, Pedrozo Z, Li DL, Morales CR, et al. Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Cell. 2014;156:1179–92.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Parker MP, Peterson KR, Slawson C. O-GlcNAcylation and O-GlcNAc cycling regulate gene transcription: emerging roles in cancer. Cancers. 2021;13:1666.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014;54:820–31.

Article  PubMed  PubMed Central  CAS  Google Scholar 

The UniProt Consortium, Bateman A, Martin M-J, Orchard S, Magrane M, Ahmad S, et al. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523–31.

Article  Google Scholar 

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2023 update. Nucleic Acids Res. 2023;51:D1373–80.

Article  PubMed  Google Scholar 

Pierce BG, Wiehe K, Hwang H, Kim B-H, Vreven T, Weng Z. ZDOCK server: interactive docking prediction of protein–protein complexes and symmetric multimers. Bioinformatics. 2014;30:1771–3.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372:774–97.

Article  PubMed  CAS  Google Scholar 

Kassambara A, Kosinski M, Biecek P, Fabian Sjdsc. Package ‘survminer.’ Drawing Survival Curves using ‘ggplot2’(R package version 03 1). (2017);

Therneau TM, Lumley T. Package ‘survival.’. R Top Doc 2015;128:28–33.

Google Scholar 

Suraokar MB, Nunez MI, Diao L, Chow CW, Kim D, Behrens C, et al. Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications. Ann Oncol. 2014;25:1184–92.

Article  PubMed  PubMed Central  CAS  Google Scholar